U.S authorizes the use of ''ArksvI'' vaccine for respiratory syncytial virus for the first time

The United States has authorized for the first time the use of a vaccine against the respiratory syncytial virus responsible for bronchiolitis, for those over the age of 60, according to the health authorities, Wednesday.